Advanced search
Publication Cover
BioTechniques Volume 65, 2018 - Issue 4
Submit an article Journal homepage
2,599
Views
2
CrossRef citations to date
0
Altmetric
Reports

T-blocker: a Simple and Robust Probe-Free Quantitative PCR Assay to Detect Somatic Mutations Down to 0.1% Frequency

Hanyoup Kim1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
,
Aaron E Ruby1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
,
Harini G Shandilya1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
,
Arvind K Virmani1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
,
Nandita Rahman1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
,
Christina M Strange1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USA
&
Jarkko Huuskonen1 Canon US Life Sciences, Inc.,9800 Medical Center Drive Suite C-120, Rockville, MD 20850, USACorrespondence[email protected]
 show all
Pages 205-210 | Received 02 Jan 2018, Accepted 26 Jul 2018, Published online: 04 Oct 2018

References

  • Gerber DE , GandhiL, CostaDB. Management and future directions in non-small cell lung cancer with known activating mutations. Am. Soc. Clin. Oncol. Educ. Booke353–e365 (2014).
  • Gonzalez de Castro D , ClarkePA, Al-LazikaniB, WorkmanP. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin. Pharmacol. Ther.93, 252–259 (2013).
  • Kalia M . Personalized oncology: recent advances and future challenges. Metabolism62(Suppl. 1), S11–S14 (2013).
  • Normanno N , RachiglioAM, RomaCet al. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities. J. Cell Biochem.114, 514–524 (2013).
  • Newton CR , GrahamA, HeptinstallLEet al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res.17, 2503–2516 (1989).
  • Bolton L , ReimanA, LucasK, TimmsJ, CreeIA. KRAS mutation analysis by PCR: a comparison of two methods. PLoS One10, e0115672 (2015).
  • Morlan J , BakerJ, SinicropiD. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoS One4, e4584 (2009).
  • Wang H , JiangJ, MostertBet al. Allele-specific, non-extendable primer blocker PCR (AS-NEPB-PCR) for DNA mutation detection in cancer. J. Mol. Diagn.15, 62–69 (2013).
  • Pender A , Garcia-MurillasI, RanaSet al. Efficient genotyping of KRAS mutant non-small cell lung cancer using a multiplexed droplet digital PCR approach. PLoS One10, e0139074 (2015).
  • Wood-Bouwens C , LauBT, HandyCM, LeeH, JiHP. Single-color digital PCR provides high-performance detection of cancer mutations from circulating DNA. J. Mol. Diagn.19, 697–710 (2017).
  • Andreyev HJ , NormanAR, CunninghmaDet al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study. Br. J. Cancer85, 692–696 (2001).
  • Bos JL , FearonER, HamiltonSRet al. Prevalence of ras gene mutations in human colorectal cancers. Nature327, 293–297 (1987).
  • Davies H , BignellGR, CoxCet al. Mutations of the BRAF gene in human cancer. Nature417, 949–954 (2002).
  • Lang AH , DrexelH, Geller-RhombergSet al. Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF. J. Mol. Diagn.13, 23–28 (2011).
  • Orue A , RieberM. Optimized multiplex detection of 7 KRAS mutations by Taqman allele-specific qPCR. PLoS One11, e0163070 (2016).
  • Li T , KungHJ, MackPC, GandaraDR. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J. Clin. Oncol.31, 1039–1049 (2013).
  • Pao W , GirardN. New driver mutations in non-small-cell lung cancer. Lancet Oncol.12, 175–180 (2011).
  • Jeong D , JeongY, LeeSet al. Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing. Korean J. Pathol.46, 61–67 (2012).
  • Satow R , HiranoT, BatoriR, NakamuraT, MurayamaY, FukamiK. Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells. Proc. Natl Acad. Sci. USA111, 13505–13510 (2014).
  • Dames S , PattisonDC, BromleyLK, WittwerCT, VoelkerdingKV. Unlabeled probes for the detection and typing of herpes simplex virus. Clin. Chem.53, 1847–54 (2007).
  • Zhou L , WangY, WittwerCT. Rare allele enrichment and detection by allele-specific PCR, competitive probe blocking, and melting analysis. Biotechniques50, 311–316 (2011).
QR code for Honorbridge. Scan the QR code or visit https://partners.honorbridge.org/research/ .
QR code for Honorbridge: We might have what your research needs. Click the QR code or visit https://partners.honorbridge.org/research/ to learn more.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.